Skip to content
Back to Investors
BGF

BGF

Venture Capital

BGF is one of the largest and most experienced growth capital investors operating across the UK and Ireland.


Recent investments

£12.0M

The Sheffield-based software provider secured the growth capital from BGF to expand its product offerings and reach.

"Tribepad has built a feature-rich platform that’s helping organisations across the country improve their ability to source and attract talent. The business is well-positioned to capitalise on favourable market tailwinds that are driving ever greater adoption of recruitment technologies as organisations look to succeed in what is an extremely tight labour market. With the support of BGF and Andy McRae as non-executive chair, I’m excited to see what Dean and the team can achieve and I look forward to working closely with the business over the next few years."
— Rob Johnson, Investor
Series C
$140M

The company has raised capital from international strategic and financial partners to accelerate its expansion across multiple industries.

"This landmark investment from world-class investors is a tremendous validation of our strategy to apply self-driving technology where there is persistent and urgent demand—in supply chains, industrial sectors, and in decongesting our cities."
— Gavin Jackson, CEO
Series B
£15.5M

The Series B financing was led by Parkwalk Advisors and BGF to support the commercial scale-up of power transistors.

"CGD is poised to become one of the leaders in enabling a sustainable world. As we move to a net-zero carbon society with rapidly increasing levels of electrification, we need clean, renewable sources of electricity and more efficient conversion methods. GaN provides the optimum conversion solution, reducing power losses by more than 50% and increasing energy conversion efficiency to above 99%. To take just one application example, if all data centres were to adopt GaN, this would save 12.4TWh of electricity per year, or 9 million tons of CO2 – the equivalent of taking 1.9 million internal combustion engines vehicles off the road for a year *. Our ICeGaN™ GaN transistors – which are now in the hands of customers at scale – are amongst the most efficient devices of their type on the market. Our devices are also the easiest for designers to use."
— Giorgia Longobardi, CEO and Founder
Series A
£10.0M

The financing round was led by BGF and Parkwalk Advisors to support platform expansion and team growth.

"These are incredibly exciting times for the genomics community and we are proud to pioneer the advent of a new era for patient-centric medicine. We are delighted to have the support of BGF, Parkwalk and our existing investors Bioqube and Jonathan Milner, which provides validation of our technology platform, GenLink3DTM."
— Debora Lucarelli, Chief Executive Officer